Arlington Capital Partners (“Arlington Capital”), a Washington, DC-based private equity firm, announced today the acquisition of Avalign Technologies (“Avalign”) from RoundTable Healthcare Partners (“RoundTable”). Avalign, based in Lake Forest, IL, is a premier, full-service precision manufacturer of implants and instruments, specialty instrumentation, cutting tools, and cases and trays to the orthopedic medical device and specialty surgical markets. Avalign offers its OEM partners a broad portfolio of manufacturing solutions and extensive engineering design, development, and project management capabilities from concept to launch. Avalign has an established reputation for consistent and sophisticated quality systems, flexible capacity capabilities, and superior customer service.
“We are delighted to partner with the Avalign team. They have built a world class enterprise that we believe has an excellent opportunity for continued growth.”
Matt Altman, a Partner at Arlington Capital said, “Avalign is an established leader in the large and growing orthopedic precision manufacturing market. Recognized across the industry for its superior engineering and manufacturing capabilities, Avalign provides significant value to its OEM partners through design improvement, speed to market acceleration and cost reductions. We look forward to partnering with the highly talented Avalign management team to support the Company through its next phase of growth.”
Forrest Whittaker, CEO of Avalign, stated, “We are extremely pleased to be partnering with Arlington Capital. Avalign is committed to improving patient outcomes by providing best-in-class medical devices through our industry leading end to end capabilities. We believe that Arlington Capital, which has deep expertise and an impressive track record in healthcare and precision manufacturing, is the ideal partner to help us achieve our goals. We would also like to thank RoundTable Healthcare Partners for all of their support and partnership to date.”
Malcolm Little, a Vice President at Arlington Capital said, “We are delighted to partner with the Avalign team. They have built a world class enterprise that we believe has an excellent opportunity for continued growth.”
About Arlington Capital Partners
Arlington Capital Partners is a Washington, D.C.-based private equity firm, whose investment funds represent over $1.5 billion of committed capital, focused on middle market investment opportunities in growth industries including: healthcare services, aerospace/defense, government services, and outsourced business services and software. The firm’s professionals and network have a unique combination of operating and private equity experience that enables Arlington to be a value-added investor. Arlington invests in companies in partnership with high quality management teams that are motivated to establish and/or advance their company’s position as leading competitors in their field. www.arlingtoncap.com
